NasdaqGS - Nasdaq Real Time Price USD
Zenas BioPharma, Inc. (ZBIO)
9.49
+0.20
+(2.15%)
As of 11:40:26 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ENAVATE SCIENCES GP, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
| ENRIGHT PATRICK G. Director | Purchase | Sep 16, 2024 | -- |
| FAIRMOUNT FUNDS MANAGEMENT LLC Director | Purchase | Sep 16, 2024 | -- |
| LU HONGBO B Director | Purchase | Sep 13, 2024 | -- |
| MOULDER LEON OLIVER JR. Chief Executive Officer | Purchase | Feb 18, 2025 | 1,938,190 |
| NUNN JASON RALEIGH Director | Purchase | Sep 16, 2024 | -- |
| SR ONE CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
| WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN I L Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 16, 2024 | 801,624 |
| XIAO TING Director | Purchase | Feb 7, 2025 | 47,000 |
Related Tickers
UPB Upstream Bio, Inc.
9.12
+3.11%
KROS Keros Therapeutics, Inc.
13.60
-2.98%
DNTH Dianthus Therapeutics, Inc.
20.44
-0.90%
MBX MBX Biosciences, Inc.
11.37
-2.90%
BCAX Bicara Therapeutics Inc.
13.04
-0.72%
SYRE Spyre Therapeutics, Inc.
14.24
+10.75%
ALMS Alumis Inc.
5.22
-1.97%
KYTX Kyverna Therapeutics, Inc.
2.1100
-0.94%
APGE Apogee Therapeutics, Inc.
37.62
-0.50%
CNTA Centessa Pharmaceuticals plc
12.32
-0.57%